Interesting views scatchback and aruc.
Agreed that receipts were low last quarter showing inconsistency in revenue generation from that source.
Cash in my opinion is OK, $1.5M on hand with upcoming $1.1M rebate and additional $450k outstanding collection.
Commercialization of PromarkerD continues to 'slowly' creep forward and those royalties will finally build a solid revenue base.
While experience has taught me never to take what stated in these reports as truth I do look forward to this upcoming update on Promarker D rollout.
"Currently licence partners cover Mexico, Dominican Republic and Spain, and Proteomics International looks forward to providing significant updates on the roll-out of PromarkerD in these jurisdictions in the coming weeks."
Interesting views scatchback and aruc. Agreed that receipts were...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.020(2.02%) |
Mkt cap ! $126.9M | |||
| Open | High | Low | Value | Volume |
| 99.0¢ | 99.0¢ | 97.0¢ | $81.47K | 83.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 21193 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 2137 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
97.0¢ |
Change
-0.020 ( 2.02 %) |
||||
| Open | High | Low | Volume | ||
| 98.5¢ | 98.5¢ | 97.0¢ | 14606 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| PIQ (ASX) Chart |